Microbiological Testing: Time is of the Essence

November 15, 2016

Cynthia A. Challener

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Pharmaceutical Technology, Pharmaceutical Technology-11-15-2016, Volume 2016 eBook, Issue 3

Pages: s33–s36

Pressures to accelerate current and next-gen therapies are challenging traditional microbiological testing models.

Effective microbiological testing during biopharmaceutical drug development and manufacturing is crucial for ensuring sterility, determining antimicrobial effectiveness, detecting microbial contamination or bioburden levels, analyzing endotoxins, and implementing environmental monitoring programs.

Growing pressures to increase productivity, flexibility, and cost-effectiveness and the unique properties of many next-generation therapies are challenging today’s microbiologists.

Download Pharmaceutical Technology’s